Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News AIM ImmunoTech Inc AIM

Healthcare Biotechnology
AIM ImmunoTech Inc. is an immuno-pharma company. It is focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases. Its flagship products are Ampligen (rintatolimod), a drug of large macromolecular ribonucleic acid (RNA) molecules, and Alferon N Injection (Interferon alfa). Its lead product is an investigational drug called... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSEAM:AIM)

AIM ImmunoTech Refutes Activist Group's False and Misleading Claims

Business Wire 1 day ago

AIM ImmunoTech Announces Cash Conservation Plan

Business Wire 1 day ago

AIM ImmunoTech Issues Presentation Detailing Case for Re-Electing Current Directors to Oversee Continued Momentum and Drive Strategy to Create Long-Term Value for Patients and Shareholders

Business Wire 3 days ago

Kellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card Now for Desperately Needed Change to the AIM Board

PR Newswire 8 days ago

AIM ImmunoTech Announces Publication of Breast Cancer Data from Roswell Park Comprehensive Cancer Center in The Journal for ImmunoTherapy of Cancer

GlobeNewswire 9 days ago

AIM ImmunoTech Reports Third Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 13 days ago

AIM ImmunoTech to Discuss Third Quarter 2024 Financial Results on November 15, 2024 and Host Conference Call and Webcast

GlobeNewswire November 6, 2024

AIM ImmunoTech Files Definitive Proxy Statement and Sends Letter to Shareholders

Business Wire November 4, 2024

AIM ImmunoTech to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC

GlobeNewswire October 9, 2024
View More News ››

Opinion & Analysis (NYSEAM:AIM)

AIM ImmunoTech Shares Soar as Japan's NIID Tests Ampligen® as Potential Coronavirus Treatment

Streetwise Reports March 10, 2020
View More Opinion ››

Bullboard Posts (NYSEAM:AIM)

Kellner Group Urges Stockholders of AIM Immunotech to Vote E

News; $AIM Kellner Group Urges Stockholders of AIM Immunotech to Vote Enclosed Gold CardAIM Stock Price Has Declined 99+% and Incumbent...
whytestocks - 2 days ago

AIM ImmunoTech Announces Print Publication and Further Posit

Breaking News: $AIM AIM ImmunoTech Announces Print Publication and Further Positive Findings from a Study Evaluating Ampligen&#xAE...
whytestocks - August 20, 2024

it's a buy today for me

at .77 cents per share,so glta shareholders.
coolfooldumbguy - January 21, 2020

AIM is aim immunotech, HEB before

 please correct your files,stockhouse.
coolfooldumbguy - January 2, 2020

formerly known as HEB,Hemisperix Biopharma

stockhouse,please correct your files.
coolfooldumbguy - January 2, 2020

this one is

on my watchlist,it was beaten up badly over the past years,but it also looks like the bottom is past on my technical charts,so a buy is...
coolfooldumbguy - January 2, 2020
View more Bullboard ››

Silver North Resources Ltd.

Silver North Resources Ltd.

Silver North Resources Ltd. is a Canada-based company, which is focused on silver discoveries in the Keno Hill Silver ...
View More »